Phospholipidomics and inflammation in sepsis

脓毒症中的磷脂组学和炎症

基本信息

  • 批准号:
    9920760
  • 负责人:
  • 金额:
    $ 29.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-15 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Sepsis remains a major cause of morbidity and mortality. Typically, 50% of all sepsis cases start as an infection in the lungs. Sepsis is accompanied by multiple organ dysfunction, cytokine storm, and disseminated coagulation syndrome. These processes directly involve vascular endothelial cells. Although inflammation, dysregulated coagulation, and alterations in endothelial permeability are recognized factors of septic acute lung injury (ALI), the endogenous mediators and cellular mechanisms orchestrating processes of endothelial inflammatory activation and coagulation in septic conditions remain poorly understood. In pilot studies we identified truncated oxidized phospholipids (TR-OxPLs) in the inflamed lungs using Mass Spectrometry-based phospholipidomics approach. Our exciting preliminary data show that TR-OxPLs markedly exacerbated lung dysfunction and impaired vascular endothelial barrier in cell and animal models of septic ALI. Using pneumonia-related models of ALI induced by live Staphylococcus aureus (S. au, USA300 CA-MRSA clinical strain 923) or heat-killed S. au (HKSA) this translational study will employ for the first time the quantitative phospholipidomics approach to identify specific TR-OxPLs elevated during ALI and elucidate their role as factors exacerbating inflammation and dysregulating coagulation cascade. We hypothesize that increased generation of TR-OxPLs during sepsis augments lung injury by inducing expression of NLRP3 inflammasome activator, thioredoxin interacting protein (TXNIP); and by suppressing the expression of vascular anticoagulant, Tissue Factor Pathway Inhibitor (TFPI). Altogether, these events lead to activation of inflammatory signaling, dysregulated coagulation, inflammatory cell infiltration in the lung, and organ damage. Aim-1 will determine the spectrum of TR-OxPL generated in the lungs of S. au-challenged animals. Aim-2 will study the impact of TR- OxPL generated in S. au-induced septic conditions on the severity of lung injury. Aim-3 will study molecular mechanisms of TR-OxPL-induced exacerbation of septic inflammation and coagulation. Aim-4 will test new mechanism-based strategies to alleviate TR-OxPLs generation and their pathologic consequences in S. au- induced septic ALI.
项目总结/文摘

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
S-Nitrosylation in endothelial cells contributes to tumor cell adhesion and extravasation during breast cancer metastasis.
内皮细胞中的S-亚硝基化有助于乳腺癌转移期间肿瘤细胞粘附和渗出。
  • DOI:
    10.1186/s40659-023-00461-2
  • 发表时间:
    2023-09-29
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Koning T;Cordova F;Aguilar G;Sarmiento J;Mardones GA;Boric M;Varas-Godoy M;Lladser A;Duran WN;Ehrenfeld P;Sanchez FA
  • 通讯作者:
    Sanchez FA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Konstantin Birukov其他文献

Konstantin Birukov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Konstantin Birukov', 18)}}的其他基金

Modulation of inflammation in aging lung
调节衰老肺部的炎症
  • 批准号:
    9901002
  • 财政年份:
    2020
  • 资助金额:
    $ 29.36万
  • 项目类别:
Modulation of inflammation in aging lung
调节衰老肺部的炎症
  • 批准号:
    10112958
  • 财政年份:
    2020
  • 资助金额:
    $ 29.36万
  • 项目类别:
Modulation of inflammation in aging lung
调节衰老肺部的炎症
  • 批准号:
    10329996
  • 财政年份:
    2020
  • 资助金额:
    $ 29.36万
  • 项目类别:
Modulation of inflammation in aging lung
调节衰老肺部的炎症
  • 批准号:
    10557197
  • 财政年份:
    2020
  • 资助金额:
    $ 29.36万
  • 项目类别:
Phospholipidomics and inflammation in sepsis
脓毒症中的磷脂组学和炎症
  • 批准号:
    9287400
  • 财政年份:
    2017
  • 资助金额:
    $ 29.36万
  • 项目类别:
2017 Grover Conference
2017年格罗弗会议
  • 批准号:
    9331900
  • 财政年份:
    2017
  • 资助金额:
    $ 29.36万
  • 项目类别:
Mechanotransduction Pathways of Endothelial Barrier Regulation
内皮屏障调节的力传导途径
  • 批准号:
    8214991
  • 财政年份:
    2011
  • 资助金额:
    $ 29.36万
  • 项目类别:
Mechanisms of Prostacyclin-Mediated Lung Endothelial Barrier Protection
前列环素介导的肺内皮屏障保护机制
  • 批准号:
    8371434
  • 财政年份:
    2008
  • 资助金额:
    $ 29.36万
  • 项目类别:
Mechanotransduction Pathways of Endothelial Barrier Regulation
内皮屏障调节的力传导途径
  • 批准号:
    7407784
  • 财政年份:
    2008
  • 资助金额:
    $ 29.36万
  • 项目类别:
Molecular control of lung endothelial barrier function in ALI
ALI 中肺内皮屏障功能的分子控制
  • 批准号:
    9916818
  • 财政年份:
    2008
  • 资助金额:
    $ 29.36万
  • 项目类别:

相似海外基金

CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
  • 批准号:
    6564818
  • 财政年份:
    2001
  • 资助金额:
    $ 29.36万
  • 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
  • 批准号:
    6410976
  • 财政年份:
    2000
  • 资助金额:
    $ 29.36万
  • 项目类别:
TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的治疗
  • 批准号:
    6370267
  • 财政年份:
    2000
  • 资助金额:
    $ 29.36万
  • 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
  • 批准号:
    6418789
  • 财政年份:
    2000
  • 资助金额:
    $ 29.36万
  • 项目类别:
TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的治疗
  • 批准号:
    6370266
  • 财政年份:
    2000
  • 资助金额:
    $ 29.36万
  • 项目类别:
TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的治疗
  • 批准号:
    6370265
  • 财政年份:
    2000
  • 资助金额:
    $ 29.36万
  • 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
  • 批准号:
    6302122
  • 财政年份:
    1999
  • 资助金额:
    $ 29.36万
  • 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
  • 批准号:
    6309780
  • 财政年份:
    1999
  • 资助金额:
    $ 29.36万
  • 项目类别:
CLINICAL MODELS OF THE ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征的临床模型
  • 批准号:
    6109540
  • 财政年份:
    1998
  • 资助金额:
    $ 29.36万
  • 项目类别:
ADHESION MOLECULES IN ADULT RESPIRATORY DISTRESS SYNDROME
成人呼吸窘迫综合征中的粘附分子
  • 批准号:
    6265845
  • 财政年份:
    1998
  • 资助金额:
    $ 29.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了